These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33212170)

  • 1. Pregnancy outcome following in-utero exposure to ondansetron: A prospective comparative observational study.
    Sakran R; Shechtman S; Arnon J; Diav-Citrin O
    Reprod Toxicol; 2021 Jan; 99():9-14. PubMed ID: 33212170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
    Bérard A; Sheehy O; Gorgui J; Zhao JP; Soares de Moura C; Bernatsky S
    J Clin Epidemiol; 2019 Dec; 116():39-48. PubMed ID: 31352006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe nausea and vomiting of pregnancy with subcutaneous medications.
    Klauser CK; Fox NS; Istwan N; Rhea D; Rebarber A; Desch C; Palmer B; Saltzman D
    Am J Perinatol; 2011 Oct; 28(9):715-21. PubMed ID: 21667429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
    Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT
    JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major Congenital Malformation Risk After First Trimester Gestational Exposure to Oral or Intravenous Ondansetron.
    Andrade C
    J Clin Psychiatry; 2020 Jun; 81(3):. PubMed ID: 32526103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study.
    Diav-Citrin O; Steinmetz-Shoob S; Shechtman S; Ornoy A
    Reprod Toxicol; 2018 Sep; 80():85-91. PubMed ID: 29857030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects.
    Parker SE; Van Bennekom C; Anderka M; Mitchell AA;
    Obstet Gynecol; 2018 Aug; 132(2):385-394. PubMed ID: 29995744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reviewing the evidence for using continuous subcutaneous metoclopramide and ondansetron to treat nausea & vomiting during pregnancy.
    Reichmann JP; Kirkbride MS
    Manag Care; 2012 May; 21(5):44-7. PubMed ID: 22670486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting.
    Mayhall EA; Gray R; Lopes V; Matteson KA
    Am J Emerg Med; 2015 Jul; 33(7):882-6. PubMed ID: 25921968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Egerton-Warburton D; Meek R; Mee MJ; Braitberg G
    Ann Emerg Med; 2014 Nov; 64(5):526-532.e1. PubMed ID: 24818542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.
    Anderka M; Mitchell AA; Louik C; Werler MM; Hernández-Diaz S; Rasmussen SA;
    Birth Defects Res A Clin Mol Teratol; 2012 Jan; 94(1):22-30. PubMed ID: 22102545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryo-fetal safety evaluation of ondansetron in rats.
    Reis ACC; Jorge BC; da Silva Moreira S; Stein J; Perdão CB; de Matos Manoel B; Arena AC
    Birth Defects Res; 2023 Apr; 115(6):605-613. PubMed ID: 36737400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study.
    Berkovitch M; Mazzota P; Greenberg R; Elbirt D; Addis A; Schuler-Faccini L; Merlob P; Arnon J; Stahl B; Magee L; Moretti M; Ornoy A
    Am J Perinatol; 2002 Aug; 19(6):311-6. PubMed ID: 12357422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting.
    Polati E; Verlato G; Finco G; Mosaner W; Grosso S; Gottin L; Pinaroli AM; Ischia S
    Anesth Analg; 1997 Aug; 85(2):395-9. PubMed ID: 9249120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death.
    Pasternak B; Svanström H; Mølgaard-Nielsen D; Melbye M; Hviid A
    JAMA; 2013 Oct; 310(15):1601-11. PubMed ID: 24129464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of metoclopramide use in the first trimester of pregnancy.
    Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
    N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nausea and vomiting in pregnancy: A place for ondansetron?].
    Coulm B
    Gynecol Obstet Fertil Senol; 2021 Dec; 49(12):947-950. PubMed ID: 34700033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ondansetron compared with metoclopramide in the treatment of established postoperative nausea and vomiting. The French Ondansetron Study Group.
    Diemunsch P; Conseiller C; Clyti N; Mamet JP
    Br J Anaesth; 1997 Sep; 79(3):322-6. PubMed ID: 9389849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting.
    Ljutić D; Perković D; Rumboldt Z; Bagatin J; Hozo I; Pivac N
    Kidney Blood Press Res; 2002; 25(1):61-4. PubMed ID: 11834879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade.
    Danielsson B; Webster WS; Ritchie HE
    Reprod Toxicol; 2018 Oct; 81():237-245. PubMed ID: 30149139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.